Figure 7.
Comparisons of the 3h FCC assay with 4 h CRA. PBMC were co-incubated with K562 targets. Non-transformed data obtained with PBMC of normal donors (n = 11) and patients with cancer (n = 15). PBMC of 12 normal donors were also stimulated with IL-2 and tested for LAK activity with Daudi targets.